Theravance Biopharma
TBPH
TBPH
98 hedge funds and large institutions have $770M invested in Theravance Biopharma in 2016 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 46 increasing their positions, 18 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
21% more funds holding
Funds holding: 81 → 98 (+17)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $79K
Holders
98
Holding in Top 10
3
Calls
–
Puts
$79K
Top Buyers
| 1 | +$43.3M | |
| 2 | +$30.8M | |
| 3 | +$25.4M | |
| 4 |
BG
Baupost Group
Boston,
Massachusetts
|
+$19.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.3M |
Top Sellers
| 1 | -$10.2M | |
| 2 | -$7.52M | |
| 3 | -$5.24M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$3.7M |
| 5 |
RA
Royce & Associates
New York
|
-$2.2M |